| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cns Pharmaceuticals, Inc. (CNSP) has 8 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. CNSP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 19.0K | $104.9K | - | |
| CEO | 9.8K | $53.9K | - | |
| CFO | 4.9K | $26.9K | - | |
| ? | 1.5K | $8.4K | - | |
| ? | 1.5K | $8.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | Evans Carl Anthony | Director | Buy | 33,333 | $0.30 | $9,999.90 | +26,666% | -13.7% | -99.2% | |
| Feb 1, 2024 | Downs Christopher | Chief Financial Officer | Buy | 66,666 | $0.30 | $19,999.80 | +181.3% | -13.7% | -99.2% | |
| Feb 1, 2024 | Climaco John M | Chief Executive Officer | Buy | 166,666 | $0.30 | $49,999.80 | +340.1% | -13.7% | -99.2% | |
| Feb 1, 2024 | Gumulka Jerzy | Director | Buy | 33,333 | $0.30 | $9,999.90 | +344.6% | -13.7% | -99.2% | |
| Aug 22, 2023 | Downs Christopher | Chief Financial Officer | Buy | 27,000 | $1.27 | $34,176.60 | +276.3% | +41.4% | -99.8% | |
| Aug 16, 2023 | Climaco John M | Chief Executive Officer | Buy | 2,750 | $1.80 | $4,944.50 | +5.9% | -8.2% | -99.8% | |
| Apr 19, 2023 | Gumulka Jerzy | Director | Buy | 2,500 | $1.70 | $4,250.00 | +34.9% | +18.6% | -88.5% | |
| Apr 17, 2023 | Downs Christopher | Chief Financial Officer | Buy | 3,100 | $3.20 | $9,920.00 | +50.4% | -22.2% | -92.4% | |
| Apr 12, 2023 | Climaco John M | Chief Executive Officer | Buy | 15,000 | $0.69 | $10,408.50 | +50.0% | +240.7% | -64.8% | |
| Apr 10, 2023 | Gumulka Jerzy | Director | Buy | 7,173 | $0.74 | $5,308.02 | New | +224.3% | -69.4% |